Macagno, A.; de Nonneville, A.; Annede, P.; Piana, G.; Pougnet, I.; Daidj, N.; Moureau-Zabotto, L.; Darreon, J.; Padovani, L.; Bertucci, F.;
et al. Repeated Multimodality Ablative Therapies for Oligorecurrent Pulmonary Metastatic Disease. Curr. Oncol. 2022, 29, 1683-1694.
https://doi.org/10.3390/curroncol29030140
AMA Style
Macagno A, de Nonneville A, Annede P, Piana G, Pougnet I, Daidj N, Moureau-Zabotto L, Darreon J, Padovani L, Bertucci F,
et al. Repeated Multimodality Ablative Therapies for Oligorecurrent Pulmonary Metastatic Disease. Current Oncology. 2022; 29(3):1683-1694.
https://doi.org/10.3390/curroncol29030140
Chicago/Turabian Style
Macagno, Alban, Alexandre de Nonneville, Pierre Annede, Gilles Piana, Isabelle Pougnet, Nassima Daidj, Laurence Moureau-Zabotto, Julien Darreon, Laetitia Padovani, Francois Bertucci,
and et al. 2022. "Repeated Multimodality Ablative Therapies for Oligorecurrent Pulmonary Metastatic Disease" Current Oncology 29, no. 3: 1683-1694.
https://doi.org/10.3390/curroncol29030140
APA Style
Macagno, A., de Nonneville, A., Annede, P., Piana, G., Pougnet, I., Daidj, N., Moureau-Zabotto, L., Darreon, J., Padovani, L., Bertucci, F., & Salem, N.
(2022). Repeated Multimodality Ablative Therapies for Oligorecurrent Pulmonary Metastatic Disease. Current Oncology, 29(3), 1683-1694.
https://doi.org/10.3390/curroncol29030140